Drug
Zolpidem Tartrate 10 mg
Zolpidem Tartrate 10 mg is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_4
2
67%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting1
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 42 (66.7%)
Trials by Status
recruiting133%
completed133%
not_yet_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_4
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
NCT05746143
not_yet_recruitingphase_4
Tizanidine vs. Zolpidem in Primary Insomnia: A Randomized Trial
NCT06303076
completedphase_2
A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)
NCT00770510
Clinical Trials (3)
Showing 3 of 3 trials
NCT05746143Phase 4
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
NCT06303076Phase 4
Tizanidine vs. Zolpidem in Primary Insomnia: A Randomized Trial
NCT00770510Phase 2
A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3